Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Colorcon
AstraZeneca
Express Scripts
McKesson
Dow

Last Updated: December 4, 2021

DrugPatentWatch Database Preview

Litigation Details for Pharmacyclics LLC v. Alvogen Pine Brook LLC (D. Del. 2019)


Email this page to a colleague

« Back to Dashboard

Pharmacyclics LLC v. Alvogen Pine Brook LLC (D. Del. 2019)

Docket ⤷  Free Forever Trial Date Filed 2019-02-28
Court District Court, D. Delaware Date Terminated 2021-08-30
Cause 35:271 Patent Infringement Assigned To Colm Felix Connolly
Jury Demand None Referred To Christopher J. Burke
Parties ALVOGEN PINE BROOK LLC; JANSSEN BIOTECH, INC.; NATCO PHARMA LTD.; PHARMACYCLICS LLC
Patents 10,004,746; 10,010,507; 10,016,435; 10,106,548; 10,106,591; 10,125,140; 10,213,386; 10,213,415; 10,294,231; 10,294,232; 10,434,140; 10,548,850; 6,346,532; 7,342,117; 7,514,444; 7,879,828; 7,982,049; 8,008,309; 8,476,284; 8,497,277; 8,563,563; 8,697,711; 8,703,780; 8,735,403; 8,754,090; 8,754,091; 8,952,015; 8,957,079; 8,999,999; 9,018,192; 9,125,889; 9,181,257; 9,192,591; 9,192,662; 9,296,753; 9,302,002; 9,386,990; 9,415,004; 9,415,009; 9,540,382; 9,655,850; 9,655,857; 9,662,415; 9,713,617; 9,725,455; 9,752,191; 9,795,604; 9,801,881; 9,801,883; 9,814,721
Attorneys Chanson Chang; Christopher D. Lynch; Cristina L. Martinez; David M. Hanna; David S. Denuyl; Hannah Lee; Irena Royzman; Jack B. Blumenfeld; James L. Higgins; Jeffrey J. Lyons; Jeremy A. Tigan; Marcus A. Colucci; Melanie K. Sharp; Michelle M. Ovanesian; Steven W. Lee
Firms Baker & Hostetler; Morris, Nichols, Arsht & Tunnell; Proskauer Rose LLP; Young, Conaway, Stargatt & Taylor LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Pharmacyclics LLC v. Alvogen Pine Brook LLC

Details for Pharmacyclics LLC v. Alvogen Pine Brook LLC (D. Del. 2019)

Date Filed Document No. Description Snippet Link To Document
2019-02-28 1 Complaint PageID #: 2 Patent”); 9,655,857 (“the ’857 Patent”); 9,725,455 (“the ’455 Patent”); 10,010,507 (“the ’507… United States Patent Nos. 7,514,444 (“the ’444 Patent”); 8,008,309 (“the ’309 Patent”); 8,476,284 (“…(“the ’284 Patent”); 8,497,277 (“the ’277 Patent”); 8,697,711 (“the ’711 Patent”); 8,735,403 (“the ’403…’403 Patent”); 8,754,090 (“the ’090 Patent”); 8,754,091 (“the ’091 Patent”); 8,952,015 (“the ’015 Patent…507 Patent”); 10,106,548 (“the ’548 Patent”); and 10,125,140 (“the ’140 Patent”). External link to document
2019-06-10 14 Amended Complaint : 1565 Patent”); 9,655,857 (“the ’857 Patent”); 9,725,455 (“the ’455 Patent”); 10,010,507 (“the ’507… United States Patent Nos. 7,514,444 (“the ’444 Patent”); 8,008,309 (“the ’309 Patent”); 8,476,284 (“…(“the ’284 Patent”); 8,497,277 (“the ’277 Patent”); 8,697,711 (“the ’711 Patent”); 8,735,403 (“the ’403…’403 Patent”); 8,754,090 (“the ’090 Patent”); 8,754,091 (“the ’091 Patent”); 8,952,015 (“the ’015 Patent…507 Patent”); 10,106,548 (“the ’548 Patent”); 10,125,140 (“the ’140 Patent”); and 10,213,386 (“the ’ External link to document
2019-06-10 15 Patent/Trademark Report to Commissioner the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,213,386 . (Blumenfeld, Jack…2019 30 August 2021 1:19-cv-00434 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Express Scripts
Harvard Business School
Merck
Colorcon
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.